Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Multi Centre Phase II, Proof of Concept, Dose Finding Clinical Trial on Ivermectin for the Early Treatment of COVID-19

NCT04438850 is registered in ClinicalTrials.gov with IRCCS Sacro Cuore Don Calabria di Negrar as lead sponsor.

NCT NCT04438850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04438850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Multi Centre Phase II, Proof of Concept, Dose Finding Clinical Trial on Ivermectin for the Early Treatment of COVID-19
Lead sponsor
IRCCS Sacro Cuore Don Calabria di Negrar
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2020
Completion date
June 8, 2021
Enrollment
93 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

covid19